跳至主要内容
临床试验/NCT05450874
NCT05450874已完成不适用

A Novel MSE Score to Predict the Postoperative Prognosis of Patients With Ruptured Hepatocellular Carcinoma

Tongji Hospital0 个研究点目标入组 300 人开始时间: 2010年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
300
主要终点
overall survival

研究概览

简要总结

Develop and validate a novel scoring system based on pathological factors to predict the postoperative survival of patients with rHCC.Patients with rHCC who underwent hepatectomy were recruited from two hospitals.Exploring whether this scoring system is related to prognosis

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • a diagnosis of ruptured tumor confirmed by enhanced computed tomography (CT) and/or abdominal magnetic resonance imaging (MRI),
  • a diagnosis of HCC made by two experienced pathologists

排除标准

  • extrahepatic HCC metastasis
  • death within 1 month after surgery

结局指标

主要结局

overall survival

时间窗: 2010-2022

Time from the first postoperative day to survival at the last follow-up

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验

A Novel MSE Score to Predict rHCC Patients | 临床试验